Peptide Ready HLA-E*01:03&B2M Monomer 蛋白, Human (HEK293, His, Avi)

The HLA-E*0103 complex is a nonclassical major histocompatibility class Ib molecule that is critical for immune self-non-self discrimination. It selectively binds the VL9 peptide from classical MHC class Ia molecules, forming a complex with B2M. Peptide Ready HLA-E*01:03&B2M Monomer Protein, Human (HEK293, His, Avi) is the recombinant human-derived HLA-E*01:03&B2M Monomer, expressed by HEK293 , with C-His, C-Avi labeled tag. ,

HLA-E*0103 复合物是一种非经典的主要组织相容性 Ib 类分子，在免疫自我-非自我辨别中发挥着关键作用。该分子与 B2M/beta-2-微球蛋白形成复合物，并选择性结合源自经典 MHC Ia 类分子信号序列的九聚体自肽，特别是 VL9 肽 (VMAPRT[V/L][L/V/I/F ]L）。肽结合的 HLA-E-B2M 异三聚体复合物作为自然杀伤 (NK) 细胞上抑制性受体 KLRD1-KLRC1 的配体，使这些细胞能够监测健康细胞中其他 MHC I 类分子的表达并耐受自身。在细胞应激期间，HLA-E*0103 优先结合来自应激诱导伴侣的信号序列衍生肽，导致 NK 细胞的保护受损。此外，它还结合来自非经典 MHC Ib 类 HLA-G 分子的信号序列衍生肽，作为 NK 细胞激活受体 KLRD1-KLRC2 的配体，可能有助于妊娠期间的适应性 NK 细胞功能和母胎耐受。此外，HLA-E*0103 可以结合并将病原体衍生的肽呈递给非常规 CD8 阳性细胞毒性 T 细胞上的 α-β T 细胞受体，从而引发抗菌免疫反应。该分子还呈现来自人类巨细胞病毒等病毒的特定肽，促进对受感染细胞的免疫耐受。

Human

HEK293

C-His;C-Avi

P13747 (G25-I305)&P61769 (I21-M119)

3133&567

50-60 kDa

Greater than 95% as determined by Tris-Bis PAGE.

无菌粉末

Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. Normally 8 % trehalose is added as protectant before lyophilization.

<1 EU/μg, determined by LAL method.

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH₂O.

Stored at -20°C for 2 years. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Room temperature in continental US; may vary elsewhere.